CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
Summary
CRISPR technology has been developed to selectively target and destroy cancer cells, including those previously considered undruggable.
Similar Articles
@smaksked: Bizarre CRISPR enzyme kills cancer cells by shredding their DNA Early tests suggest the protein can be aimed at targets…
A new CRISPR-based enzyme shows promise in early tests for targeting tumor-causing mutations and shredding cancer DNA.
Colon cancer’s invisibility cloak removed by eliminating a single gene - a fundamental breakthrough. The result was 100% eradication of tumours when paired with immunotherapy treatment in mouse models.
New University of Calgary research shows that knocking out a single gene makes colon cancer cells visible to the immune system, and when combined with immunotherapy, leads to 100% tumor eradication in mouse models, offering a potential new approach for treating colorectal cancer.
There's An AI For That: the first AI cancer drug just worked
AI is transforming both ends of cancer care: Recursion's REC-617 became the first AI-designed drug to shrink tumors in a patient within 12 months, AI-assisted mammography found 30% more cancers in a 100k-person Swedish trial, and AlphaFold uncovered a hidden cell-transport switch (AVL9) that turns out to be an off-switch for cancer metastasis. Yet no AI-designed cancer drug is approved, and the historic 90% clinical trial failure rate remains unbroken.
Team uses AlphaFold AI to redesign gene-editing proteins to make them safer
Researchers used AlphaFold AI to identify and redesign parts of gene-editing proteins (Cas9) responsible for off-target effects, significantly improving safety by reducing unintended edits.
Anthropic Says It Discovered a Crispr-Like System. Now What?
Anthropic claims its AI model Claude discovered an enzyme system reminiscent of CRISPR, potentially advancing gene editing, though scientists emphasize the need for further validation.